Caledon, Ontario, Sept. 03, 2021 (GLOBE NEWSWIRE) — CardioGenics Holdings Inc. (OTC PINK: CGNH) (the “Company”)announced today that its subsidiary, CardioGenics Inc. (“CardioGenics”), has entered into a license agreement with Covidgenics Corp., a private company located in Ontario, which grants to Covidgenics an exclusive 10-year global license of the Company’s proprietary technology for its QL Care Analyzer and paramagnetic beads.